CT-P10: Clinical Trials

15 trials of CT-P10, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 active not recruiting, 3 completed, 3 recruiting, 1 terminated. 15 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 315Active not recruiting 8, Completed 3, Recruiting 3, Terminated 1
Phase 23Active not recruiting 2, Recruiting 1

Follow CT-P10: new trials by email Literature Review of CT-P10 trials Research Report on CT-P10

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Addition of a New Anti-Cancer Drug, Glofitamab to Usual Chemotherapy for Burkitt and Double Hit Lymphoma
Biospecimen Collection, Bone Marrow Biopsy, Carboplatin - Recurrent Burkitt Lymphoma, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements
Phase 2 / Phase 3RecruitingNational Cancer Institute (NCI)2712027-07-272026-11-17
Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial
Biospecimen Collection, Computed Tomography, Cyclophosphamide - Richter Syndrome, Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma
Phase 3RecruitingSWOG Cancer Research Network1022026-08-042026-10-13
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Biospecimen Collection, Computed Tomography, Mosunetuzumab - Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3RecruitingNational Cancer Institute (NCI)6002024-10-232026-11-18
Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
Biospecimen Collection, Bone Marrow Aspiration, Busulfan - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 3Active not recruitingChildren's Oncology Group662023-03-152026-07-30
Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Primary Mediastinal Large B-Cell Lymphoma
Phase 3Active not recruitingNational Cancer Institute (NCI)2442021-10-052026-11-04
Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma
Biospecimen Collection, Computed Tomography, Cyclophosphamide - Ann Arbor Stage III Diffuse Large B-Cell Lymphoma, Ann Arbor Stage IIX (Bulky) Diffuse Large B-Cell Lymphoma
Phase 2 / Phase 3Active not recruitingNational Cancer Institute (NCI)4222021-05-202026-11-12
Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas
Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography - Diffuse Large B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Phase 2 / Phase 3Active not recruitingNational Cancer Institute (NCI)3632019-10-222026-11-12
Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission
Autologous Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Aspirate - Mantle Cell Lymphoma
Phase 3Active not recruitingECOG-ACRIN Cancer Research Group6892017-11-272026-09-14
To Compare Efficacy and Safety Between CT-P10 and Rituxan in Patients With Low Tumour Burden Follicular Lymphoma
CT-P10, Rituxan - Follicular Lymphoma
Phase 3CompletedCelltrion2582015-11-092021-04-08
Rituximab With or Without Yttrium Y-90 Ibritumomab Tiuxetan in Treating Patients With Untreated Follicular Lymphoma
Quality-of-Life Assessment, Rituximab, Yttrium Y-90 Ibritumomab Tiuxetan - Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2 Follicular Lymphoma
Phase 3TerminatedMayo Clinic202015-02-112025-07-09
PK Similarity Prospective Phase 3 Study in Patients With Rheumatoid Arthritis
CT-P10, Rituxan, MabThera - Rheumatoid Arthritis
Phase 3CompletedCelltrion3842014-08-012021-12-16
To Demonstrate Equivalence of Pharmacokinetics and Noninferiority of Efficacy for CT-P10 in Comparison With Rituxan
Rituxan, CT-P10, Cyclophosphamide - Lymphoma, Follicular
Phase 3CompletedCelltrion1402014-07-142020-01-29
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Allogeneic Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Blinatumomab - Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
Phase 3Active not recruitingNational Cancer Institute (NCI)4882014-05-192026-11-18
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Cyclophosphamide, Fludarabine Phosphate, Ibrutinib - Anemia, Chronic Lymphocytic Leukemia
Phase 3Active not recruitingNational Cancer Institute (NCI)5292014-03-102026-08-28
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
Bendamustine Hydrochloride, Biospecimen Collection, Bone Marrow Aspiration - Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia
Phase 3Active not recruitingNational Cancer Institute (NCI)5472014-01-152026-11-16

Conditions studied

Burkitt Lymphoma (2)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (2)  ·  Lymphoma, Follicular (2)  ·  Lymphoma, Large B-Cell, Diffuse (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Anemia (1)  ·  Arthritis, Rheumatoid (1)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma, B-Cell, Marginal Zone (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Myelodysplastic Syndromes (1)

Sponsors

National Cancer Institute (NCI) (8)  ·  Celltrion (3)  ·  Children's Oncology Group (1)  ·  ECOG-ACRIN Cancer Research Group (1)  ·  Mayo Clinic (1)  ·  SWOG Cancer Research Network (1)

Countries

United States (12)  ·  Canada (4)  ·  Australia (2)  ·  Puerto Rico (2)  ·  Israel (1)  ·  Saudi Arabia (1)  ·  South Korea (1)

Top investigators

DaeHyun Yoo, M.D., Ph.D (1)  ·  Elizabeth A Brem (1)  ·  Heather J Symons (1)  ·  Jennifer A Woyach (1)  ·  Jeremy S Abramson (1)  ·  Kristie A Blum (1)  ·  Lisa G Roth (1)  ·  Mark R Litzow (1)  ·  Mazyar Shadman (1)  ·  Nilanjan Ghosh (1)  ·  SungHyun Kim (1)  ·  Tait D Shanafelt (1)  ·  Thomas E. Witzig, M.D. (1)  ·  Timothy S Fenske (1)

Results publications

PMID 28712940, PMID 30010481, PMID 30389036, PMID 30501481, PMID 30719632, PMID 31184752, PMID 31365801, PMID 32589970, PMID 33288485, PMID 33439748, PMID 34274940, PMID 34477816, PMID 34634256, PMID 34686445, PMID 34686472, PMID 34865212, PMID 35427411, PMID 36485104, PMID 37801678, PMID 38215395, PMID 39047240, PMID 42660130, PMID 42832396

NIH funding

U10CA180820 (3), U10CA180821 (3), U10CA180888 (3), U10CA021115 (2), U10CA180886 (2), U24CA196172 (2), K23CA178183 (1), R01CA183444 (1), R01CA193541 (1), U10CA031946 (1)